Cite
HARVARD Citation
Molica, S. et al. (2022). Adherence to ibrutinib remains an unmet clinical need in chronic lymphocytic leukemia. Leukemia & lymphoma. 63 (8), pp. 1771-1773. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Molica, S. et al. (2022). Adherence to ibrutinib remains an unmet clinical need in chronic lymphocytic leukemia. Leukemia & lymphoma. 63 (8), pp. 1771-1773. [Online].